Section Arrow
Quote
MTNB.NYSE-M
- Matinas Biopharma Holdings Inc
(Financial Status)
Quotes are at least 15-min delayed:2026/08/31 17:09 EDT
After Hours
Last
 0.1968
-0.0009 (-0.46%)
Bid
0.1901
Ask
0.197
High 0.1977 
Low 0.193 
Volume 8.55K 
Regular Hours (Closed)
Last
 0.1977
-0.0023 (-1.15%)
Day High 
0.197799 
Prev. Close
0.2 
1-M High
0.44 
Volume 
418.09K 
Bid
0.1901
Ask
0.197
Day Low
0.1871 
Open
0.1947 
1-M Low
0.178 
Market Cap 
2.94M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.2 
20-SMA 0.23 
50-SMA 0.38 
52-W High 2.14 
52-W Low 0.178 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-1.15/-1.50
Enterprise Value
3.60M
Balance Sheet
Book Value Per Share
0.12
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.22
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CLGNCollPlant Biotechnologies Ltd0.3879+0.0299+8.35%-- 
After Hours 0.3666 -0.0213 -5.49%
AIMAIM ImmunoTech Inc.0.226-0.0324-12.54%-- 
After Hours 0.2315 +0.0055 +2.43%
ROIVRoivant Sciences Ltd34.64-0.07-0.20%-- 
After Hours 35.8942 +1.2542 +3.62%
CVKDCadrenal Therapeutics Inc1.75+0.21+13.64%-- 
After Hours 1.6 -0.15 -8.57%
MRNAModerna140.34+2.35+1.70%-- 
After Hours 139.0767 -1.2633 -0.90%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.